Skip to main content
. 2020 Sep 15;12(9):e10474. doi: 10.7759/cureus.10474

Figure 2. Forest plot—Individual study proportions and the pooled estimate of 90-day survival with granulocyte colony stimulating factor (G-CSF) therapy in severe alcoholic hepatitis (AH) (fixed effects).

Figure 2